GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Trimeris, Inc. (TRMS) [hlAlert]

Trimeris, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology
platform of fusion inhibition is based on blocking viral entry into host cells. FUZEON, approved in the U.S., Canada and European Union, is the first in a new class of anti-HIV drugs called fusion inhibitors. Trimeris is developing FUZEON and future generations of peptide fusion inhibitors in collaboration with F. Hoffmann-La Roche Ltd.
( Total: 1 Current Stock Recommendations )
Trimeris, Inc.   (1)
Hold 100%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
3/4/2009  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy